Pure Global AI
NCT05910268Not yet recruiting

Peru Decentralized HIV Care

Innovations in Decentralizing HIV Services in Peru
Yale UniversityClinicalTrials.govbehavioral
Verified
Study focus
Disease/Condition
HIV
Drug/Device/Intervention
NIATx + ECHO
Study type
Interventional
Intervention type
behavioral
Sponsor & location
Primary sponsor
Yale University
Location
New Haven,Bellavista, Peru,United States of America
Timeline & enrollment
Phase
N/A
Start date
Jul 01, 2023
End date
Jul 01, 2028
Enrollment
1450 participants
Primary outcome

Percentage of diagnosed PWH in treatment in PHC within the district

Summary

The purpose of this study is to understand the processes by which HIV care is decentralized,
 an evidence-informed strategy to improve retention in HIV care, in Peru. Decentralization of
 HIV services has not been evaluated using experimental designs and urban decentralization
 studies of HIV are uncommon, so this study will lend important insights for future
 decentralization efforts in Peru and other countries.

ICD-10 classifications
Human immunodeficiency virus [HIV] diseaseHuman immunodeficiency virus [HIV] disease resulting in other conditionsHIV disease resulting in other viral infectionsUnspecified human immunodeficiency virus [HIV] diseaseHuman immunodeficiency virus [HIV] disease resulting in other specified diseases
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT05910268
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT05910268 through Pure Global AI's free database. This phase not specified trial is sponsored by Yale University and is currently Not yet recruiting. The study focuses on HIV. Target enrollment is 1450 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.